Avanos Medical, Inc. (AVNS)

NYSE: AVNS · IEX Real-Time Price · USD
31.59
-0.16 (-0.50%)
Feb 3, 2023, 4:00 PM EST - Market closed
-0.5%
Market Cap 1.47B
Revenue (ttm) 795.90M
Net Income (ttm) 42.90M
Shares Out 46.50M
EPS (ttm) 0.90
PE Ratio 35.10
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 195,347
Open 31.44
Previous Close 31.75
Day's Range 31.43 - 31.89
52-Week Range 19.32 - 35.91
Beta 0.88
Analysts Sell
Price Target 28.90 (-8.52%)
Earnings Date Feb 22, 2023

About AVNS

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear... [Read more]

Industry Medical Devices
Sector Healthcare
CEO Joseph Woody
Employees 4,555
Stock Exchange NYSE
Ticker Symbol AVNS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for AVNS stock is "Sell." The 12-month stock price forecast is $28.9, which is a decrease of -8.52% from the latest price.

Price Target
$28.9
(-8.52% downside)
Analyst Consensus: Sell
Stock Forecasts

News

Avanos Medical, Inc. Announces New Leadership Appointments

ALPHARETTA, Ga. , Jan. 11, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced two executive leadership appointments that support the company's long-term strategic priorities: Micha...

3 weeks ago - PRNewsWire

Avanos Medical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

ALPHARETTA, Ga. , Jan. 4, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 41st Annual J.P.

1 month ago - PRNewsWire

3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023

Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.

Other symbols: DYNTINGN
2 months ago - Zacks Investment Research

3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio

Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.

2 months ago - Zacks Investment Research

Avanos Medical (AVNS) Up 21% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

Avanos Medical, Inc. Appoints Sudhakar Varshney as Senior Vice President, Global Supply Chain & Procurement

ALPHARETTA, Ga. , Nov. 14, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Sudhakar Varshney has been appointed senior vice president, global supply chain & procurement.

2 months ago - PRNewsWire

Avanos Medical, Inc. to Present at the Stifel 2022 Healthcare Conference

ALPHARETTA, Ga. , Nov. 8, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial...

3 months ago - PRNewsWire

Avanos (AVNS) Q3 Earnings Surpass Estimates, Margins Up

Avanos' (AVNS) third-quarter 2022 results reflect strength in the Pain Management segment.

3 months ago - Zacks Investment Research

Avanos Medical (AVNS) Tops Q3 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of 5.56% and 1.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Avanos Medical, Inc. Announces Third Quarter 2022 Results

ALPHARETTA, Ga. , Nov. 2, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2022 financial results.

3 months ago - PRNewsWire

Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2022 Financial Results

ALPHARETTA, Ga. , Oct. 26, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2022 on We...

3 months ago - PRNewsWire

Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

New Strong Sell Stocks for October 5th

AVNS, NKE and PLAB have been added to the Zacks Rank #5 (Strong Sell) List on October 5, 2022.

Other symbols: NKEPLAB
4 months ago - Zacks Investment Research

New Strong Sell Stocks for September 28th

AVNS, ARCE and DCO have been added to the Zacks Rank #5 (Strong Sell) List on September 28, 2022.

Other symbols: ARCEDCO
4 months ago - Zacks Investment Research

Avanos Medical (AVNS) Down 14% Since Last Earnings Report: Can It Rebound?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

Avanos Medical, Inc. To Present at the Morgan Stanley 20th Annual Global Healthcare Conference

ALPHARETTA, Ga. , Sept. 7, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financia...

5 months ago - PRNewsWire

7 Safe Small-Cap Stocks to Buy Now

Let's begin by defining the realm of small-cap stocks before we discuss those that appear to be strong, safe investments currently. As their name implies, small-cap stocks have lower market capitaliza...

Other symbols: ACMRBKDGPREMXSSTKSWBI
6 months ago - InvestorPlace

Avanos (AVNS) Q2 Earnings Top Estimates, FY22 View Lowered

Avanos's (AVNS) second-quarter 2022 results reflect strength in the Pain Management segment.

6 months ago - Zacks Investment Research

Avanos Medical (AVNS) Surpasses Q2 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of 5.13% and 2.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Avanos Medical, Inc. Announces Second Quarter 2022 Results

ALPHARETTA, Ga. , Aug. 9, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2022 financial results.

6 months ago - PRNewsWire

Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2022 Financial Results

ALPHARETTA, Ga. , July 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2022 on T...

6 months ago - PRNewsWire

Avanos Medical (AVNS) to Report Q2 Results: Wall Street Expects Earnings Growth

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

7 Undervalued Small-Cap Stocks to Buy Now

These undervalued small-cap stocks to buy do have value and could outperform in both the short term and long term. The post 7 Undervalued Small-Cap Stocks to Buy Now appeared first on InvestorPlace.

Other symbols: BCCGFFJBTPRLBSONOSSTK
7 months ago - InvestorPlace

Can Avanos Medical (AVNS) Keep the Earnings Surprise Streak Alive?

Avanos Medical (AVNS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

7 months ago - Zacks Investment Research

Here's Why You Should Hold on to Avanos (AVNS) Stock For Now

Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.

8 months ago - Zacks Investment Research